Additionally, the Keap1/Nrf2/HO-1 signaling pathway, which is activated by antioxidants such as tectorigenin, plays a role in reducing oxidative stress and inflammation in asthma, suggesting a potential therapeutic synergy with Trx1 [105]. Here, NFE2L2 is linked to asthma.